Steroids and #PMR In this Tuesday Night Rheumatology webinar, the panel discussed the use of corticosteroids in patients with polymyalgia rheumatica. Panelists: Drs. Lindsay Lally, Richard Conway and Max Yates. Moderated by Dr. David Liew. https://t.co/t27SldsJ9z https://t.co/8knPPLw3OE

53.2 Million with Diagnosed Arthritis (USA: 2019–2021) Last week the CDC's MMWR reports that during 2019–2021, 21.2% of U.S. adults (53.2 million) reported "diagnosed arthritis" https://t.co/UKtR0q40cU https://t.co/9Wb1dAtzDJ

Curious about the latest updates in treating axSpA? Don't miss out on the RheumNow Therapeutic Update! This engaging video series explores the current recommendations from the ASAS-EULAR Guidelines. https://t.co/Zto7we8z6M https://t.co/TvXzsFUZ46

Innovative, full-read, state-of-the-art article on IMAGING in INFLAMMATORY ARTHRITIS & its future role in precision medicine. "Imaging is poised to become an invaluable tool in precision medicine..". HR-pQCT, 3T or 7T MRI, FAPI PET–CT, CEUS, FOI, etc https://t.co/JlZZf2KZdi https://t.co/eSpE9RAcvB

Canadian survey of 620 pts w/ chronic & debilitating arthritis, shows the majority (76%) are free of psychiatric disorders (76%) & in good (complete) mental health (56%); fostered by having a confidant, & being without insomnia, depression/anxiety https://t.co/6agOYCmnit https://t.co/IBKCjUo0DQ

Turkish study 1,134 PsA pts found mean Dx delay=35 mos (median: 12). 39% Dx w/in 3 mos, & 67% w/in 24 mos. Dx delay decr. over time: 60 to 24 mos (<2010 to 2015–2019). Dx delay factors: less education (OR 2.6), arthritis>PSO (1.7), LBP 1st (1.6)https://t.co/GYKPSaYWhU https://t.co/YYwaiQd5mJ

Tomorrow! Join us for #PMR & Steroid-Sparing Therapeutics featuring panelists Drs. Robert Spiera and Sarah Mackie, and moderator Dr. Sebastian Sattui . https://t.co/UjtWAvSOXU https://t.co/LbZKybkAzK

FDA Approves IV Secukinumab On 10/6/23, Novartis announced the FDA approved an IV formulation of secukinumab (Cosentyx) for use in treating adults with PsA, ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) https://t.co/zv7b98ZUjS https://t.co/1rXjYIbLpw

Full Read review of #PMR in Lancet: - Start @ 12·5–25mg prednisone qd - Remission in most but, relapses in 40–60% - Onset sudden; AM stiffness predominates; Shoulders>Pelvic ~50% have distal MSK Sxs - US: look for B/L sub-acromial/deltoid bursitis https://t.co/0j1nRmdizP https://t.co/7cURm1pQeB

#PMR: glad or bad tidings? Please don’t tell your patient that PMR “typically” lasts two years. Because it probably won’t last exactly two years, and then they’ll be less inclined to believe other things you say. Read more... https://t.co/UXuUzEVjFI @sarah_L_mackie https://t.co/UnXsyuq4V4

Hepatotoxicity related to Anakinra has been reported in pediatric rheumatology patients. LFT elevations have been reported with IL-1 inhibition, even after excluding LFTs from the inflamm Dx, other drugs, MAS, etc. Here are 3 case reports. https://t.co/6ZxIcHbUEd https://t.co/Cx0kbn7JU2